Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY)

Completed · Phase 3

Conditions studied: Infection, Bone Neoplasms

In brief

The Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY) trial is the first ever international multi-center randomized controlled trial in bone cancer surgery. In order to avoid amputation for bone cancer in the leg, complex limb-saving operations are performed. However, infections with devastating complications following surgery are common. Surgeons from across the world will randomize patients to receive either short- or long-duration antibiotic regimens after surgery with the goal of identifying the best regimen to reduce these infections.

Key facts

Study ID
NCT01479283
Run by
McMaster University
People needed
602
Starts
2013-01-01
Expected to finish
2021-03-01
Last updated by the study team
2021-03-11

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.